Shigeo Watabe

493 total citations
25 papers, 418 citations indexed

About

Shigeo Watabe is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Shigeo Watabe has authored 25 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cellular and Molecular Neuroscience, 15 papers in Molecular Biology and 9 papers in Pharmacology. Recurrent topics in Shigeo Watabe's work include Neuroscience and Neuropharmacology Research (22 papers), Cholinesterase and Neurodegenerative Diseases (8 papers) and Nicotinic Acetylcholine Receptors Study (7 papers). Shigeo Watabe is often cited by papers focused on Neuroscience and Neuropharmacology Research (22 papers), Cholinesterase and Neurodegenerative Diseases (8 papers) and Nicotinic Acetylcholine Receptors Study (7 papers). Shigeo Watabe collaborates with scholars based in Japan and United States. Shigeo Watabe's co-authors include Mitsunobu Yoshii, Tadashi Shiotani, Tamotsu Nomura, Tomoyuki Nishizaki, Shin-ichiro Ashida, Hitoshi Yamaguchi, Toshiyuki Matsuoka, Katumi Sumikawa, Takeo Sakurai and Toshitaka Nabeshima and has published in prestigious journals such as Brain Research, Annals of the New York Academy of Sciences and Molecular Pharmacology.

In The Last Decade

Shigeo Watabe

25 papers receiving 399 citations

Peers

Shigeo Watabe

CMN

PHARM

PMH

Pál Berzsenyi Hungary

Tadashi Shiotani Japan

F Andrási Hungary

Richard E. Garey United States

David M. Otte Germany

James C. Blosser United States

Anne B. Need United States

Kate E. Gilling Germany

Nigel Deeks United Kingdom

Corrado Carignani Italy

Pál Berzsenyi Hungary

Shigeo Watabe

317 ×1.1

CMN

224 ×0.9

59 ×0.5

PHARM

56 ×1.0

PMH

37 ×0.7

Citations per year, relative to Shigeo Watabe Shigeo Watabe (= 1×) peers Pál Berzsenyi

Countries citing papers authored by Shigeo Watabe

Since Specialization

Citations

This map shows the geographic impact of Shigeo Watabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeo Watabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeo Watabe more than expected).

Fields of papers citing papers by Shigeo Watabe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeo Watabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeo Watabe. The network helps show where Shigeo Watabe may publish in the future.

Co-authorship network of co-authors of Shigeo Watabe

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeo Watabe. A scholar is included among the top collaborators of Shigeo Watabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeo Watabe. Shigeo Watabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakamoto, Yurie, Tadashi Shiotani, Shigeo Watabe, Toshitaka Nabeshima, & Mitsunobu Yoshii. (2004). Nootropic Nefiracetam Inhibits Proconvulsant Action of Peripheral‐Type Benzodiazepines in Epileptic Mutant EL Mice. Annals of the New York Academy of Sciences. 1025(1). 135–139. 3 indexed citations

Yoshii, Mitsunobu, Taiji Furukawa, Shigeo Watabe, et al.. (2004). Negative Regulation of Opioid Receptor‐G Protein‐Ca²⁺ Channel Pathway by the Nootropic Nefiracetam. Annals of the New York Academy of Sciences. 1025(1). 389–397. 2 indexed citations

Jin, Jingji, Shigeo Watabe, & Tsuneyuki Yamamoto. (2002). Nefiracetam Improves the Impairment of Local Cerebral Blood Flow and Glucose Utilization after Chronic Focal Cerebral Ischemia in Rats. Pharmacology. 64(3). 119–125. 8 indexed citations

Woodruff‐Pak, Diana S., et al.. (2002). The long-term effects of nefiracetam on learning in older rabbits. Behavioural Brain Research. 136(1). 299–308. 5 indexed citations

Nishizaki, Tomoyuki, Toshiyuki Matsuoka, Tamotsu Nomura, et al.. (2000). Presynaptic Nicotinic Acetylcholine Receptors As a Functional Target of Nefiracetam in Inducing a Long-lasting Facilitation of Hippocampal Neurotransmission. Alzheimer Disease & Associated Disorders. 14(Supplement). S82–S94. 18 indexed citations

Shiotani, Tadashi, Yurie Nakamoto, Shigeo Watabe, Mitsunobu Yoshii, & Toshitaka Nabeshima. (2000). Anticonvulsant actions of nefiracetam on epileptic EL mice and their relation to peripheral-type benzodiazepine receptors. Brain Research. 859(2). 255–261. 16 indexed citations

Yoshii, Mitsunobu, Shigeo Watabe, Yoshiya L. Murashima, Toshihide Nukada, & Tadashi Shiotani. (2000). Cellular Mechanism of Action of Cognitive Enhancers: Effects of Nefiracetam on Neuronal Ca2+ Channels. Alzheimer Disease & Associated Disorders. 14(Supplement). S95–S102. 15 indexed citations

Nishizaki, Tomoyuki, Tamotsu Nomura, Takeshi Kondoh, et al.. (2000). The anti-dementia drug nefiracetam facilitates hippocampal synaptic transmission by functionally targeting presynaptic nicotinic ACh receptors. Molecular Brain Research. 80(1). 53–62. 34 indexed citations

Nishizaki, Tomoyuki, Toshiyuki Matsuoka, Tamotsu Nomura, et al.. (1999). A `long-term-potentiation-like' facilitation of hippocampal synaptic transmission induced by the nootropic nefiracetam. Brain Research. 826(2). 281–288. 36 indexed citations

10.

Sakurai, Takeo, et al.. (1998). Nefiracetam elevates extracellular acetylcholine level in the frontal cortex of rats with cerebral cholinergic dysfunctions: an in vivo microdialysis study. Neuroscience Letters. 246(2). 69–72. 31 indexed citations

11.

Nishizaki, Tomoyuki, Toshiyuki Matsuoka, Tamotsu Nomura, et al.. (1998). Nefiracetam Modulates Acetylcholine Receptor Currents via Two Different Signal Transduction Pathways. Molecular Pharmacology. 53(1). 1–5. 44 indexed citations

12.

Yoshii, Mitsunobu, Tomoyuki Nishizaki, & Shigeo Watabe. (1998). Facilitatory actions of the cognitive enhancer nefiracetam on neuronal Ca2+ channels and nicotinic ACh receptors: Their intracellular signal transduction pathways. Folia Pharmacologica Japonica. 112(supplement). 41–43. 1 indexed citations

13.

Yoshii, Mitsunobu, Shigeo Watabe, Takeo Sakurai, & Tadashi Shiotani. (1997). Cellular mechanisms underlying cognition-enhancing actions of nefiracetam (DM-9384). Behavioural Brain Research. 83(1-2). 185–188. 20 indexed citations

14.

Nakamoto, Yurie, Shigeo Watabe, Tadashi Shiotani, & Mitsunobu Yoshii. (1996). Peripheral-type benzodiazepine receptors in association with epileptic seizures in EL mice. Brain Research. 717(1-2). 91–98. 18 indexed citations

15.

Yoshii, Mitsunobu & Shigeo Watabe. (1994). Enhancement of neuronal calcium channel currents by the nootropic agent, nefiracetam (DM-9384), in NG108-15 cells. Brain Research. 642(1-2). 123–131. 70 indexed citations

16.

Watabe, Shigeo, Mitsunobu Yoshii, Nobukuni Ogata, Akinobu Tsunoo, & Toshio Narahashi. (1993). Differential inhibition of transient and long-lasting calcium channel currents by benzodiazepines in neuroblastoma cells. Brain Research. 606(2). 244–250. 16 indexed citations

17.

Watabe, Shigeo, Hitoshi Yamaguchi, & Shin-ichiro Ashida. (1993). DM-9384, a new cognition-enhancing agent, increases the turnover of components of the GABAergic system in the rat cerebral cortex. European Journal of Pharmacology. 238(2-3). 303–309. 44 indexed citations

18.

Murashima, Yoshiya L., et al.. (1991). DM-9384, a cyclic GABA derivative, elevates the c-AMP level in NG108-15 cells. Neuroscience Research Supplements. 16. 61–61. 4 indexed citations

19.

Watabe, Shigeo, et al.. (1990). Effect of DM-9384, a new cognition-enhancing agent, on GABA and cholinergic systems in rat cortex. The Japanese Journal of Pharmacology. 52. 294–294. 2 indexed citations

20.

Ishikawa, Koichi, et al.. (1986). Effects of various tricyclic antidepressants on amine uptake. European Journal of Pharmacology. 120(1). 63–68. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact